Prediction of Risk of Death for Patients Starting Dialysis
- 30 July 2019
- journal article
- review article
- Published by Wolters Kluwer Health in Clinical Journal of the American Society of Nephrology
- Vol. 14 (8) , 1213-1227
Abstract
Background and objectives: Dialysis is a preference-sensitive decision where prognosis may play an important role. Although patients desire risk prediction, nephrologists are wary of sharing this information. We reviewed the performance of prognostic indices for patients starting dialysis to facilitate bedside translation. Design, setting, participants, & measurements: Systematic review and meta-analysis following the PRISMA guidelines. We searched Ovid MEDLINE, Ovid Embase, Ovid Central Register of Controlled Trials, Ovid Cochrane Database of Systematic Reviews, and Scopus for eligible studies of patients starting dialysis published from inception to December 31, 2018. Selection Criteria: Articles describing validated prognostic indices predicting mortality at the start of dialysis. We excluded studies limited to prevalent dialysis patients, AKI and studies excluding mortality in the first 1–3 months. Two reviewers independently screened abstracts, performed full text assessment of inclusion criteria and extracted: study design, setting, population demographics, index performance and risk of bias. Pre-planned random effects meta-analysis was performed stratified by index and predictive window to reduce heterogeneity. Results: Of 12,132 articles screened and 214 reviewed in full text, 36 studies were included describing 32 prognostic indices. Predictive windows ranged from 3 months to 10 years, cohort sizes from 46 to 52,796. Meta-analysis showed discrimination area under the curve (AUC) of 0.71 (95% confidence interval, 0.69 to 073) with high heterogeneity (I 2=99.12). Meta-analysis by index showed highest AUC for The Obi, Ivory, and Charlson comorbidity index (CCI)=0.74, also CCI was the most commonly used (ten studies). Other commonly used indices were Kahn-Wright index (eight studies, AUC 0.68), Hemmelgarn modification of the CCI (six studies, AUC 0.66) and REIN index (five studies, AUC 0.69). Of the indices, ten have been validated externally, 16 internally and nine were pre-existing validated indices. Limitations include heterogeneity and exclusion of large cohort studies in prevalent patients. Conclusions: Several well validated indices with good discrimination are available for predicting survival at dialysis start.Keywords
Funding Information
- National Institute on Aging (K23AG051679)
- National Institute of Diabetes and Digestive and Kidney Diseases (K23 DK109134)
- Foundation for the National Institutes of Health (UL1 TR000135)
This publication has 68 references indexed in Scilit:
- The New Comorbidity Index for Predicting Survival in Elderly Dialysis Patients: A Long-Term Population-Based StudyPLOS ONE, 2013
- Ageism vs the technical imperative applying the GRADE framework to the evidence on hemodialysis in very elderly patientsClinical Interventions in Aging, 2013
- Development of a decision aid to inform patients’ and families’ renal replacement therapy selection decisionsBMC Medical Informatics and Decision Making, 2012
- Discussions of the Kidney Disease Trajectory by Elderly Patients and Nephrologists: A Qualitative StudyAmerican Journal of Kidney Diseases, 2012
- Predicting Mortality in Incident Dialysis Patients: An Analysis of the United Kingdom Renal RegistryAmerican Journal of Kidney Diseases, 2011
- End-of-Life Care Preferences and NeedsClinical Journal of the American Society of Nephrology, 2010
- Assessing the Performance of Prediction ModelsEpidemiology, 2010
- Functional Status of Elderly Adults before and after Initiation of DialysisNew England Journal of Medicine, 2009
- A clinical score to predict 6-month prognosis in elderly patients starting dialysis for end-stage renal diseaseNephrology Dialysis Transplantation, 2008
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987